PLSE Stock Analysis: Buy, Sell, or Hold?
PLSE - Pulse Biosciences, Inc Common Stock (DE)
$18.10
0.15 (0.84%)
▲
5d:
-5.78%
30d:
+32.02%
90d:
+34.27%
HOLD
LOW Confidence
Analysis Updated: Mar 4, 2026 12:00 AM ET
Earnings: Feb 19, 2026
0d
Smart Money Accumulation
PLSE is down 5.5% this week, but smart money is accumulating calls. Top strike: $17 2026-04-17 with 81 OI. Call ratio: 100% View Scanner →
Strength: 7.7/10
Get Alerted When PLSE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: PLSE shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: PLSE shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: PLSE is currently trading at $18.10, which is considered fair relative to its 30-day fair value range of $14.88 to $23.17.
Technical Outlook: Technically, PLSE is in a uptrend. Immediate support is located at $17.46, while resistance sits at $25.61.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $22.00 (+21.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, PLSE is in a uptrend. Immediate support is located at $17.46, while resistance sits at $25.61.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $22.00 (+21.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$14.88 -
$23.17
Company Quality Score
53/100
(HOLD)
Options IV Signal
69th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
73.8%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Options fairly priced (IV 69th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 21.5% below Wall St target ($22.00)
- CAUTION: Recommendation downgraded due to -5.8% 5-day decline
Fair Price Analysis
30-Day Fair Range
$14.88 -
$23.17
Current vs Fair Value
FAIR
Expected Move (7 Days)
±$2.83
(15.6%)
Support & Resistance Levels
Support Level
$17.46
Resistance Level
$25.61
Current Trend
Uptrend
Technical data as of
Mar 4, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-10.90
Wall Street Target
$22.00
(+21.5%)
Share & Embed Analysis
Last updated: March 05, 2026 3:57 AM ET
Data refreshes hourly during market hours. Next update: 4:57 AM
Data refreshes hourly during market hours. Next update: 4:57 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PLSE showing a specific setup today?
Insider Activity (6 Months)
1
Buys
10
Sells
Net
INSIDERS SELLING
Recent Transactions
Kevin Patrick Danahy
SELL
20000 shares
2026-02-17
Kevin Patrick Danahy
SELL
20000 shares
2026-02-13
Kevin Patrick Danahy
SELL
20000 shares
2026-02-11
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$92 | 64 BUY |
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$611 | 60 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$191 | 50 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$341 | 61 BUY |
|
RMD
ResMed Inc |
BUY
19 analysts |
$297 | 59 HOLD |
